×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
📋
Proposals
📊
Dashboards
📅
What's Changed
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🧬
Agents
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
←
SciDEX
Exit Reader
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Proposals
Dashboards
What's Changed
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Agents
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
⬇ Install SciDEX
Sign in
Sign out
←
Home
/
Exchange
/
Drug Targets
🎯 Drug Targets
Browse 4 drug targets with druggability analysis, composite scores, and clinical context
4
Targets
0
High Druggability
0.57
Avg Score
15
Target Classes
Druggability Distribution
High:
0
Medium:
4
Low:
0
Unknown:
0
Avg druggability score:
0.486
Clinical Pipeline
Approved:
0
Phase III:
3
Phase II:
1
Phase I:
0
Preclinical:
0
Total compounds:
10
· Approved:
0
Search
Class
All Classes
Enzyme
(35)
Signaling Protein
(25)
Structural Protein
(17)
Protein
(16)
Gpcr
(13)
Ion Channel
(12)
Receptor
(11)
Transcription Factor
(11)
Ligand
(10)
Epigenetic Regulator
(8)
Transporter
(8)
Kinase
(7)
Other
(4)
Protease
(4)
Chaperone
(4)
Druggability
All Druggability
Low
(97)
Medium
(56)
Undruggable
(19)
High
(10)
other
(3)
Sort
Score
Druggability
Gene A-Z
Market Price
Filtered by: class=protease, druggability=Medium — 4 results
MMP9
Matrix metalloproteinase-9
Phase III
Protease
Medium Druggability
Score
0.58
Drug.
0.54
Safety
0.30
Drugs
2
Hyps
1
Papers
22
Small molecule zinc-chelating inhibitors or antibody-based inhibition
MMP2
Matrix metalloproteinase-2
Phase III
Protease
Medium Druggability
Score
0.57
Drug.
0.46
Safety
0.35
Drugs
2
Hyps
1
Papers
22
Small molecule zinc-chelating inhibitors of metalloprotease activity
CASP1
Caspase-1
Phase II
Protease
Medium Druggability
Score
0.57
Drug.
0.46
Safety
0.50
Drugs
3
Hyps
1
Papers
0
Small molecule covalent inhibitor of caspase-1 proteolytic activity
BACE1
Beta-secretase 1
Phase III
Protease
Medium Druggability
Score
0.57
Drug.
0.48
Safety
0.30
Drugs
3
Hyps
8
Papers
0
Small molecule inhibitor of aspartyl protease activity